Sutro Biopharma Financial Flexibility Index
Sutro Biopharma financial flexibility index. Sutro Biopharma (STRO) has a Financial Flexibility Index of -0.13x as of June 2026. Free cash flow of $-38.29 Million (operating CF $-38.29 Million minus capex $0.00) represents 0% of total liabilities ($297.78 Million). See STRO cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sutro Biopharma (2016–2025)
Financial flexibility index of Sutro Biopharma from 2016 to 2025. Historical Financial Flexibility Index trend for Sutro Biopharma across 10 annual periods. Check Sutro Biopharma (STRO) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Sutro Biopharma Financial Flexibility Index by Year (2016–2025)
Sutro Biopharma financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Sutro Biopharma. For the full cash flow conversion analysis, see STRO operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.57x | $-175.54 Million | $-177.23 Million | $306.28 Million | ▼ -4.2% |
| 2024 | -0.55x | $-188.44 Million | $-191.54 Million | $342.61 Million | ▼ -64.6% |
| 2023 | -0.33x | $-107.30 Million | $-111.62 Million | $321.09 Million | ▼ -656.3% |
| 2022 | 0.06x | $11.41 Million | $3.55 Million | $189.90 Million | ▲ +108.0% |
| 2021 | -0.75x | $-66.36 Million | $-81.68 Million | $88.84 Million | ▲ +23.6% |
| 2020 | -0.98x | $-60.67 Million | $-67.80 Million | $62.06 Million | ▲ +6.9% |
| 2019 | -1.05x | $-61.54 Million | $-65.02 Million | $58.58 Million | ▼ -775.8% |
| 2018 | 0.16x | $14.24 Million | $12.68 Million | $91.60 Million | ▲ +169.0% |
| 2017 | -0.23x | $-33.76 Million | $-37.07 Million | $149.77 Million | ▼ -312.2% |
| 2016 | -0.05x | $-8.76 Million | $-13.15 Million | $160.18 Million | — |